Buprenorphine Neuraxpharm

Medicinal product

(Invented) name

Buprenorphine Neuraxpharm

Active substance (s)

Buprenorfinas

Strength

4 mg

Pharmaceutical form

poliežuvinė plėvelė

Route (s) of administration

vartoti po liežuviu

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N07BC01, Buprenorphine

Marketing authorisation holder

Neuraxpharm Pharmaceuticals, S.L., Ispanija

Date of authorisation

2024-12-19

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

Yes

Controlled substance type

Narkotinis

Legal basis

10(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Plėvelėje yra:	1 vnt.
Buprenorfinas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116084	102185	1102185	paketėlis	N7×1		Receptinis	EU/1/24/1809/004	Netiekiama	-	-	No	-	-
116085	102186	1102186	paketėlis	N28×1		Receptinis	EU/1/24/1809/005	Netiekiama	-	-	No	-	-
116086	102187	1102187	paketėlis	N56×1		Receptinis	EU/1/24/1809/006	Netiekiama	-	-	No	-	-
117611	103714	1103714	paketėlis	N49×1		Receptinis	EU/1/24/1809/014	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-12-19	Registruotas